2,4-Diaminoquinoline Substituted as a New Drug for Fibrosis, Autophagy, and Cathepsin B (CTSB), L (CTSL), and D (CTSD) Related Disorders
MA43495AUndetermined Publication Date: 2020-09-23GENOSCIENCE PHARMA SAS
0 Cites 0 Cited by
Patent Information
- Application Number
- MA43495
- Authority / Receiving Office
- MA · MA
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2018-09-05
- Publication Date
- 2020-09-23
Need to check novelty before this filing date? Find Prior Art
No text content released.